Drug intelligence / Profile preview

PlantForm E. coli antibody

Development stage
Preclinical
Lead developer
PlantForm
Modality
Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics
Administration
Oral
01

Overview

PlantForm Corporation is developing an edible antibody therapeutic produced using its tobacco-plant-based vivoXPRESS® platform to prevent *Escherichia coli* (E. coli) O157 infections in livestock, particularly pigs. The therapeutic consists of antibody fragments that target *E. coli* and inhibit its ability to colonize the epithelial cells of the gut wall. Intended for delivery as a low-cost, minimally processed feed additive, the product aims to reduce the shedding of viable bacteria, thereby breaking the cycle of infection and transmission among animals and potentially reducing the risk of zoonotic transmission to humans. This research project was supported by the Ontario Agri-Food Research Initiative and involves collaboration with Agriculture and Agri-Food Canada (AAFC) and Western University.

Other names
edible E. coli antibody therapeuticvivoXPRESS E. coli antibody

Beyond the preview

Go deeper on PlantForm E. coli antibody.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PlantForm E. coli antibody.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call